USC employees are invited to participate in the Trojan Pandemic Response Initiative, a new study that will survey 8,000 students, staff and faculty, and follow some of them over the course of a year to better understand attitudes and behaviors related to COVID-19 and COVID-19 vaccines.
Data from this study could provide insights that will help the university’s ongoing efforts to minimize infections, create shareable data with other USC researchers, and provide valuable information as we all strive to end this pandemic. The study is funded by Keck COVID-19 Research Fund, the USC Office of the Provost, and the USC Office of Research.
What happens if I enroll?
If you agree to participate in the study, you’ll be asked to complete an online survey. You may be asked to complete additional surveys every three months for one year. Some will be asked to share blood, saliva, and urine samples to test their immune response to COVID-19 vaccines. This part is completely optional. Participation is completely voluntary and at no cost to employees. Personal information will be kept confidential and will only be known to study investigators.
Subjects will receive a $10 e-gift card for completing a brief survey and up to $150 in e-gift cards for their contributions, depending on the extent of their participation.
How do I sign up?
Please go to https://cprc.usc.edu/tpri to participate.
Who are the researchers involved?
The Principal Investigator of the study is Dr. Howard Hu, the Flora L. Thornton Chair of the Department of Preventive Medicine, Keck School of Medicine. He is joined by Lourdes Baezconde-Garbanati, PhD, professor of preventive medicine; David Conti, PhD, a professor of biostatistics; Frank Gilliland, MD, PhD, professor of preventive medicine; Jeffrey Klausner, MD, MPH, clinical professor of preventive medicine; Andrea Kovacs, MD, professor of pediatrics, pathology and preventive medicine; Sarah Van Orman, MD, Associate Vice Provost for Student Affairs and Chief Student Health Officer; Jennifer Unger, PhD, professor of preventive medicine; and Paul Anderson, research scientist.
Who do I contact for more information?